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Short Communication
THE PAL TEST FOR MALIGNANT DISEASE IN MAN
W. AX, S. SCHOTTLER AND H. W. BAUER
From the Behringwerke AG, 355 Marburg, Germiany
Receive(i 3 October 1977
IT was recently shown that the
improvement of the histone-induced
agglutination of lymphocytes (Sabolovic
et al., 1975) by synthetic peptides (Bauer
and Ax, 1977) might also be of interest in
detecting malignancies. As opposed to all
other tests mentioned, the poly-L-lysine-
induced agglutination test (PAL test) is
simple, rapid and requires a minimum of
laboratory practice. By screening a large
population the present study should
confirm the extent of agreement between
microagglutination induced by poly-L-
lysine of mol. wt r-3400 and malignant
growth.
Patients.-Studies were performed on
300 persons of both sexes and of all ages
with the PAL test described in detail
earlier (Bauer and Ax, 1977). Ninety of
them had malignant tumours, 140 had
non-malignant or pre-malignant diseases.
For the purpose of further comparison, 70
healthy controls were also tested. All
3 groups were of comparable range of age
and sex. Patients with non-malignant
diseases were mainly those with acute or
chronic conditions, especially inflamma-
tions ofthe gastrointestinal and urogenital
tracts, the lung and the bile-duct system.
Lymphocytes.-Lymphocytes were pre-
pared from heparinized or citrated blood
by Ficoll-Isopaque® gradient as described
by English and Anderson (1974) using
2 layers of separating fluid of sp.gr. (a)
1]077 and (b) 1-119 at 25°C. The plasma-
solution (a) interface consists of lympho-
cytes (90%0), solution (a)-(b) interface of
polymorphonuclear cells (80%).
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Test procedure. 1 ml of lymphocytes,
diluted with Hanks' solution to a concen-
tration of6 X 106/ml, was mixed with 1 ml
of basic peptide poly-L-lysine mol.wt 3400
of 0 05 mg/ml dissolved in 0 145M NaCl,
pH 7*0. The mixture was distributed into
microplates, 20 ,ul per well, and incubated
for 30 min at 37°C in a humid atmosphere.
Results. Of the 70 normal subjects,
none showed positive results in the test
(Table I). In the 140 patients with non-
malignant disease the blood lymphocytes
showedpositivereactionsin24%- 33/140
cases (Table I). By contrast, 81% -73/90
cases of the patients with neoplastic
disease showed agglutination (Table II).
Negative reactions were found mainly in
patients with advanced metastases. We
did not find a difference between patients
with a tumour and those who were
tumour-free long after surgery (6 cases,
1-12 months after tumour resection).
When the reactionwith thepoly-L-lysine
fraction was very strong, all cells were
agglutinated, but if the cell concentration
was reduced below the value given in the
test procedure above, no agglutination
occurred at all. This demonstrates the
importance of a sufficient lymphocyte
concentration per well for cells to contact
each other, before a positive reaction
can occur. The extended findings of the
test described here seem to confirm the
value of this procedure for detecting
"malignancy" in man. A relatively simple
"blood-test" for neoplasm is of consider-
able interest as a scanning procedure.W. AX, S. SCHOTTLER AND H. W. BAUER
TABLE I.-Poly-L-lysine Agglutination (PAL) Test in Patients with
Non-malignant Diseases and Healthy Controls
Peripheral lymphocytes from patients with
Cholecystopathy
Diabetes mellitus
Appendicitis
Ulcerative colitis
Hernia inguinalis
Goitre and hyperthyroidism
Pulmonary embolus
Pneumonia + chronic bronchitis
Nephritis
Rectal polyp
Hypertonus
Rheumatoid arthritis
Attempted suicide (barbiturate)
Generalized arteriosclerosis + heart attack
Haemorrhoids
Mononucleosis
Prostatic adenoma
Porphyria cut. tarda
Pancreatitis, chronic
Diverticulitis
Eczema
Lymphoma, benign
Thalassaemia
Ovarian cyst
Hep'atitis
Ulcus ventriculi
Hypogonadism
Morbus Werlhof
Stomatitis
Polyneuropathy
IgA-Plasmocytoma
Mucocoele
Abscess
Trauma
Total
HEALTHY CONTROLS
Results
+ - Total
8 11 19
0 13 13
2 9 11
4 2 6
2 5 7
1 6 7
0 4 4
1 4 5
3 6 9
3 2 5
1 5 6
1 6 7
0 1 1
0 10 10
1 3 4
0 2 2
0 1 1
0 1 1
3 0 3
0 2 2
1
1
0
0
0
0
0
0
0
0
0
0
0
3.3(24%)
0
1
1
0
1
2
1
1
1
1
1
1
1
1
1
107 (76%)
70
2
2
1
1
2
1
1
1
14
10
70
TABLE II.-Poly-L-lysine Agglutination (PAL) Test in Cancer Patients
Site of carcinoma
Thyroid
Bronchus
Breast
Stomach
Pancreas
Colon, sigmoid
Rectum
Kidney
Prostate
Corpus uteri
Ovary
Testis
Malignant lymphoma
Melanoma
Sarcoma
Total
Results
+ - Total
2
4
8
10
4
12
14
5
1
2
2
1
5
2
1
73 (81%)
1
2
3
2
1
2
1
1
0
0
0
0
1
2
1
3
6
11
12
5
14
15
6
1
2
2
1
6
4
2
17 (19%) 90
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Despite unexpected findings, we are confi-
dent of our results, even though we can
still present no satisfactory explanation
for the underlying mechanism(s).
It is a pleasure to acknowledge the helpful
cooperation of the surgeons (Professor H. Richter
and Professor G. Rodeck) and the physicans (Dr
W. D. Gassl and Dr G. Walch) of the Universitats-
klinikum Marburg for blood samples and access to
patients.
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